其它产品项目整合

项目整合的本质是一项集合成方法学、反应工程学与过程分析技术于一体的系统工程。其核心逻辑可以概括为以下几点：源头优选：利用如N-硝胺化学等底层方法学突破，从分子层面颠覆传统高成本、高污染路线。过程强化：依托连续流技术，攻克有机金属试剂应用、光化学反应放大等“不可能”任务，实现高危工艺的本质安全。系统集成：整合“反应-淬灭-分离”全流程，利用微流控与在线分析技术，消除批次间的差异，实现药品制造的连续化与智能化。当前，中间体工艺研发正在经历从“经验驱动”向“数据驱动”的转变。AI辅助路线设计、自动化高通量筛选与连续制造平台的结合，将使得“分子结构与最优工艺路径”之间的映射关系逐渐清晰。未来的竞争优势，将属于那些能够将底层化学创新与先进工程技术进行无缝整合的研发体系。
备注: 根据相关法律法规, 本站点不显示有法律约束管制的产品, 如有遗漏, 请自行鉴别,或提交我们及时更新撤除.
如有产品相关项目调研推广服务, 请致函联系我们

客户展示

其它产品项目整合

Voriconazole CAS Registry Number: 137234-62-9 伏立康唑

CAS Name: (aR,bS)-a-(2,4-Difluorophenyl)-5-fluoro-b-methyl-a-(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimideethanol
Additional Names: 2R,3S-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,...
Literature References: Ergosterol biosynthesis inhibitor. Prepn: S. J. Ray, K. Richardson, EP 440372; eidem, US 5278175 (1991, 1994 both to Pfizer); R. P. Dickinson et al., Bioorg. Med. Chem. Lett. 6, 2031 (1996). Mechanism of action: H. Sanati et al., Antimicrob. Agents Chemother. 41, 2492 (1997). In vitro antifungal spectrum: F. Marco et al., ibid. 42, 161 (1998). HPLC determn in plasma: R. Gage, D. A. Stopher, J. Pharm. Biomed. Anal. 17, 1449 (1998). Review of pharmacology and clinical development: P. E. Verweij et al., Curr. Opin. Anti-Infect. Invest. Drugs 1, 361-372 (1999); J. A. Sabo, S. M. Abdel-Rahman, Ann. Pharmacother. 34, 1032-1043 (2000). Clinical pharmacokinetics: L. Purkins et al., Antimicrob. Agents Chemother. 46, 2546 (2002). Clinical comparison with amphotericin B: T. J. Walsh et al., N. Engl. J. Med. 346, 225 (2002).

Terguride CAS Registry Number: 37686-84-3 特麦角脲

CAS Name: N,N-Diethyl-N'-[(8a)-6-methylergolin-8-yl]urea
Additional Names: N-(D-6-methyl-8-isoergolin-1-yl)-N',N'-diethylurea; 6-methyl-8a-(diethylcarbamoylamino)ergoline; 9,10a-dihydrolisuride...
Literature References: Ergot derivative; dihydrogenated analog of lisuride, q.v. Exhibits dopamine agonist and antagonist activity. Prepn: V. Zikán et al., Collect. Czech. Chem. Commun. 37, 2600 (1972); eidem, DE 2238540; eidem, US 3953454 (1973, 1976 both to Spofa). Physical properties: A. Cerny et al., Collect. Czech. Chem. Commun. 52, 1331 (1987). Pharmacology in animals and humans: H. Wachtel, R. Dorow, Life Sci. 32, 421 (1983). Receptor binding studies in rat brain: W. Kehr et al., Acta Pharm. Suec. 1983, Suppl. 2, 98; M. W. Valchár et al., Eur. J. Pharmacol. 136, 97 (1987). Evaluation in animal models of Parkinson's disease: W. C. Koller, G. Herbster, Neurology 37, 723 (1987); T. Brücke et al., Eur. J. Pharmacol. 148, 445 (1988). Radioreceptor assay in biological fluids: R. Lapka et al., J. Pharmacol. Methods 11, 263 (1984). Pharmacokinetics in humans: W. Krause et al., Eur. J. Clin. Pharmacol. 27, 335 (1984). Clinical evaluation in Huntington's disease: S. Bassi et al., Neurology 36, 984 (1986); in Parkinson's disease: T. Brücke et al., Adv. Neurol. 45, 573 (1986); I. Suchy et al., ibid. 577; in hyperprolactinemia and acromegaly: D. Dallabonzana et al., J. Clin. Endocrinol. Metab. 63, 1002 (1986).

Phenylalanine CAS Registry Number: 63-91-2 L-苯丙氨酸

CAS Name: L-Phenylalanine
Additional Names: Phe; F; b-phenylalanine; a-aminohydrocinnamic acid; (S)-2-amino-3-phenylpropanoic acid; a-amino-b-phenylpropionic acid
Percent Composition: C 65.4...
Literature References: Essential amino acid for human development. Originally isolated from the sprouts of lupine: E. Schulze, J. Barbieri, Ber. 12, 1924 (1879). Early chemistry and biochemistry: Amino Acids and Proteins, D. M. Greenberg, Ed. (Charles C. Thomas, Springfield, IL, 1951) 950 pp. passim; J. P. Greenstein, M. Winitz, Chemistry of the Amino Acids vols 1-3 (John Wiley and Sons, Inc., New York, 1961) pp. 2156-2177, passim. Synthesis from L-tyrosine: V. Viswanatha, V. J. Hruby, J. Org. Chem. 45, 2010 (1980). Colorimetric determn in blood: R. S. Campbell et al., Ann. Clin. Biochem. 31, 140 (1994). Effects on food intake: G. H. Anderson, L. A. Leiter, Appetite 11, Suppl. 48 (1988); P. J. Rogers, J. E. Blundell, Physiol. Behav. 56, 247 (1994). Clinical trial in vitiligo: C. Antoniou et al., Int. J. Dermatol. 28, 545 (1989); A. H. Siddiqui et al., Dermatology 188, 215 (1994). Review of metabolism: H. N. Munro, J. Toxicol. Environ. Health 2, 189-206 (1976). Review of role in phenylketonuria: S. P. Bessman, Nutr. Rev. 37, 209-220 (1979); F. Güttler, Acta Paediatr. Scand. 73, 705-716 (1984). Review of microbial production: T. K. Maiti, S. P. Chatterjee, Hind. Antibiot. Bull. 32, 3-26 (1990).

Carnitine CAS Registry Number: 541-15-1 左旋肉碱

CAS Name: (2R)-3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium inner salt
Additional Names: L-(3-carboxy-2-hydroxypropyl)trimethylammonium hydroxide inner salt; (-)-b-hydroxy-g-trimethylami...
Literature References: Essential cofactor of fatty acid metabolism; required for the transport of fatty acids through the inner mitochondrial membrane. Synthesized primarily in the liver and kidney; highest concentrations found in heart and skeletal muscle. Named derived from the Latin word, carnis, meaning meat or flesh. Dietary sources include red meat, dairy products, beans, avocado. Isoln from meat extract: W. Gulewitsch, R. Krimberg, Z. Physiol. Chem. 45, 326 (1905); H. E. Carter, P. K. Bhattacharyya, Methods Enzymol. III, 660 (1957). Identification as vitamin BT: H. E. Carter et al., Arch. Biochem. Biophys. 38, 405 (1952). Synthesis: M. Tomita, Y. Sendju, Z. Physiol. Chem. 169, 263 (1927); R. Voeffray et al., Helv. Chim. Acta 70, 2058 (1987). Enantioselective synthesis from glycerol: M. Marzi et al., J. Org. Chem. 65, 6766 (2000). Biosynthesis: G. Wolf, C. R. A. Berger, Arch. Biochem. Biophys. 92, 360 (1961). Absolute configuration: T. Kaneko, R. Yoshida, Bull. Chem. Soc. Jpn. 35, 1153 (1962). Metabolism in humans: M. E. Mitchell, Am. J. Clin. Nutr. 31, 293 (1978). Historical review: G. Fraenkel, S. Friedman, Vitam. Horm. XV, 73-118 (1957). Review of physiological significance and deficiency syndromes: C. J. Rebouche, D. J. Paulson, Annu. Rev. Nutr. 6, 41-66 (1986); of clinical pharmacology: J. J. Bahl, R. Bressler, Annu. Rev. Pharmacol. Toxicol. 27, 257-277 (1987); of biosynthesis in mammals: F. M. Vaz, R. J. A. Wanders, Biochem. J. 361, 417-429 (2002). Review of effect on myocardial metabolism and clinical experience in ischemic heart disease: R. Lango et al., Cardiovasc. Res. 51, 21-29 (2001); of use as dietary supplement in athletes: H. Karlic, A. Lohninger, Nutrition 20, 709-715 (2004). Symposium on physiology, pharmacology and therapeutic potential: Ann. N.Y. Acad. Sci. 1033, 1-197 (2004).

Temsirolimus CAS Registry Number: 162635-04-3 西罗莫司脂化物

CAS Name: Rapamycin 42-[3-Hydroxy-2-(hydroxymethyl)-2-methylpropanoate]
Additional Names: rapamycin 42-ester with 2,2-bis-(hydroxymethyl)propionic acidPercent Composition: C 65.28%, H 8.51%, N ...
Literature References: Ester analog of rapamycin, q.v.; selectively inhibits mammalian target of rapamycin (mTOR). Prepn: J. S. Skotnicki et al., US 5362718 (1994 to Am. Home Prod.). Lipase-catalyzed synthesis from rapamycin: J. Gu et al., Org. Lett. 7, 3945 (2005). Clinical pharmacology: E. Raymond et al., J. Clin. Oncol. 22, 2336 (2004). Clinical study in advanced refractory renal cell carcinoma: M. B. Atkins et al., ibid. 909. Clinical evaluation in glioblastoma multiforme: E. Galanis et al., J. Clin. Oncol. 23, 5294 (2005); in breast cancer: S. Chan et al., ibid. 5314; in mantle cell lymphoma: T. E. Witzig et al., ibid. 5347.

Amtolmetin Guacil CAS Registry Number: 87344-06-7 呱氨托美丁

CAS Name: N-[[1-Methyl-5-(4-methylbenzoyl)-1H-pyrrol-2-yl]acetyl]glycine 2-methoxyphenyl ester
Additional Names: N-[(1-methyl-5-p-toluoylpyrrol-2-yl)acetyl]glycine o-methoxyphenyl ester; 1-meth...
Literature References: Ester prodrug of tolmetin, q.v. Prepn: A. Baglioni, BE 896018; idem, US 4578481 (1983, 1986 both to Sigma-Tau). Pharmacology: E. Arrigoni-Martelli, Drugs Exp. Clin. Res. 16, 63 (1990); A. Caruso et al., ibid. 18, 481 (1992). HPLC determn in plasma: A. Mancinelli et al., J. Chromatogr. 553, 81 (1991). Series of articles on pharmacokinetics and clinical trials: Clin. Ter. 142 (1 pt 2) 3-59 (1993).

Acacia CAS Registry Number: 9000-01-5 阿拉伯胶

Additional Names: Gum Arabic
Literature References: Estimations of mol wt range from about 240,000: Oakley, Trans. Faraday Soc. 31, 136 (1935), to 580,000: Anderson et al., Carbohydr. Res. 3, 308 (1967). According to the U.S.P., acacia is the dried gummy exudation from the stems and branches of Acacia senegal (L.) Willd., Leguminosae, or other African species of Acacia. According to C. L. Mantell, The Water-Soluble Gums (New York, 1947), Kordofan gum (hashab geneina), the gum from Acacia verek Guill. Perr. from plantations in the Kordofan province (Sudan) is considered the best commercial variety. Grades of Kordofan gum which are clear, white (sun bleached) and tasteless are preferred for food prepns and pharmaceuticals. (There is a close relationship between color and flavor due to the presence of tannins.) Acacia was originally thought to be composed only of (-)-arabinose, (+)-galactose, (-)-rhamnose, (+)-glycuronic acid. Revised composition and structural studies: Anderson et al., J. Chem. Soc. C 1966, 1959. See also Swenson et al., J. Polym. Sci. Part A-2 6, 1593 (1968). General review: Anderson, Dea, J. Soc. Cosmet. Chem. 22, 61-76 (1971). Review of use as food additive: D. M. W. Anderson, Food Addit. Contam. 3, 225-230 (1986).

Epimestrol CAS Registry Number: 7004-98-0 表美雌醇

CAS Name: (16a,17a)-3-Methoxyestra-1,3,5(10)-triene-16,17-diol
Additional Names: 3-methoxy-17-epiestriolTrademarks: Stimovul (Organon)
Percent Composition: C 75.46%, H 8.67%, O 15.87%
Literature References: Estriol deriv, which stimulates ovulation. Prepn: J. de Visser, NL 95275 (1960 to Organon), C.A. 55, 22378d (1961); L. Caglioti, M. Magi, Tetrahedron Lett. 1962, 1261; eidem, Tetrahedron 19, 1127 (1963). 13C-NMR study: T. A. Wittstruck, K. I. H. Williams, J. Org. Chem. 38, 1542 (1973). Proton NMR and configurational study: B. Schoenecker et al., J. Prakt. Chem. 319, 419 (1977). Clinical chemistry: G. Falkay et al., Clin. Chim. Acta 44, 209 (1973). Comparative study in rats: D. Bentue-Ferrer et al., Ann. Endocrinol. 41, 203 (1980). Effects in normal men: M. Luisi et al., Reproduccion 4, 77 (1980), C.A. 93, 89260 (1980).

Centchroman CAS Registry Number: 31477-60-8 苯并吡喃

CAS Name: rel-1-[2-[4-[(3R,4R)-3,4-Dihydro-7-methoxy-2,2-dimethyl-3-phenyl-2H-1-benzopyran-4-yl]phenoxy]ethyl]pyrrolidine
Additional Names: (trans)-1-[2-[p-(7-methoxy-2,2-dimethyl-3-phenyl-4-ch...
Literature References: Estrogen antagonist; synthetic nonsteroidal postcoital antifertility agent. Pharmacology: V. P. Kamboj et al., Indian J. Exp. Biol. 9, 103 (1971); idem et al., ibid. 15, 1144 (1977). Prepd (not claimed): J. W. Bolger, DE 2329201 (1974 to Riker); idem, US 3822287 (1974 to Rexall); S. Ray et al., J. Med. Chem. 19, 276 (1976). Mechanism of action: M. S. Sankaran, M. R. N. Prasad, Contraception 9, 279 (1974). Clinical pharmacology: R. Vaidya et al., ibid. 1173. Physicochemical properties: R. K. Seth et al., Indian J. Pharm. Sci. 45, 14 (1983). Resolution and stereoselective binding of enantiomers: M. Salman et al., J. Med. Chem. 29, 1801 (1986). Absolute configuration: N. Srivastava et al., Bioorg. Med. Chem. Lett. 6, 1747 (1996). HPLC determn in serum and milk: J. Lal et al., J. Chromatogr. B 658, 193 (1994). Clinical pharmacokinetics: idem et al., Contraception 52, 297 (1995). Toxicity: I. M. Chak et al., Indian J. Exp. Biol. 15, 1159 (1977). Review of clinical experience: M. M. Singh, Med. Res. Rev. 21, 302-347 (2001).

Zearalenone CAS Registry Number: 17924-92-4 玉米赤霉烯酮

CAS Name: (3S,11E)-3,4,5,6,9,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione
Additional Names: 6-(10-hydroxy-6-oxo-trans-1-undecenyl)-b-resorcylic acid lactone; ...
Literature References: Estrogenic mycotoxin produced by Fusarium fungi commonly found in grains. One of a group of compounds known as resorcylic acid lactones. Isoln from the mycelia of Gibberella zeae (Fusarium graminearum): M. Stob et al., Nature 196, 1318 (1962); F. N. Andrews, M. Stob, US 3196019 (1965 to Purdue Res. Found.). Structure: W. H. Urry et al., Tetrahedron Lett. 1966, 3109. Synthesis of dl-form: D. Taub et al., Chem. Commun. 1967, 225; NL 6812148; N. N. Girotra, N. L. Wendler, US 3551455 (1968, 1970 both to Merck Co.); Vlattas et al., J. Org. Chem. 33, 4176 (1968); T. Takahashi et al., Tetrahedron Lett. 22, 1363 (1981). Total synthesis and abs config: D. Taub et al., Tetrahedron 24, 2443 (1968). Physicochemical data: A. E. Pohland et al., Pure Appl. Chem. 54, 2219 (1982). Natural occurrence in agricultural products: T. Tanaka et al., J. Agric. Food Chem. 36, 979 (1988). GC determn in cereals: K. Schwadorf, H.-M. Müller, J. Chromatogr. 595, 259 (1992).